fluoxetine has been researched along with Lipid Metabolism Disorders in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Lipid Metabolism Disorders: Pathological conditions resulting from abnormal anabolism or catabolism of lipids in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Fluoxetine (FLX) is the first selective serotonin reuptake inhibitor to be widely available for the treatment of depression." | 7.88 | Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression. ( Liu, J; Pan, SJ; Tan, YL; Xin, Y; Xiong, J; Yang, X; Yao, SW, 2018) |
| " Fluoxetine (FLX) is the first selective serotonin reuptake inhibitor to be widely available for the treatment of depression." | 3.88 | Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression. ( Liu, J; Pan, SJ; Tan, YL; Xin, Y; Xiong, J; Yang, X; Yao, SW, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, SJ | 1 |
| Tan, YL | 1 |
| Yao, SW | 1 |
| Xin, Y | 1 |
| Yang, X | 1 |
| Liu, J | 1 |
| Xiong, J | 1 |
1 other study available for fluoxetine and Lipid Metabolism Disorders
| Article | Year |
|---|---|
Fluoxetine induces lipid metabolism abnormalities by acting on the liver in patients and mice with depression.
Topics: Adult; Animals; Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; Cholesterol; Depression; Femal | 2018 |